S
Sandrine Crane
Researcher at Wake Forest University
Publications - 2
Citations - 197
Sandrine Crane is an academic researcher from Wake Forest University. The author has contributed to research in topics: Odds ratio & Performance status. The author has an hindex of 2, co-authored 2 publications receiving 129 citations.
Papers
More filters
Journal ArticleDOI
Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial
Angela Tatiana Alistar,Bonny Morris,Rodwige Desnoyer,Heidi D. Klepin,Keyanoosh Hosseinzadeh,Clancy J. Clark,Amy Cameron,John R. Leyendecker,Ralph B. D'Agostino,Umit Topaloglu,Lakmal W. Boteju,Asela R Boteju,Rob Shorr,Zuzana Zachar,Paul M. Bingham,Tamjeed Ahmed,Sandrine Crane,Riddhishkumar Shah,John J Migliano,Timothy S. Pardee,Lance D. Miller,Gregory A. Hawkins,Guangxu Jin,Wei Zhang,Boris Pasche +24 more
TL;DR: The primary objective was to establish the maximum tolerated dose of CPI-613 (as assessed by dose-limiting toxicities) in patients with newly diagnosed metastatic pancreatic adenocarcinoma.
Journal ArticleDOI
Frailty assessment predicts toxicity during first cycle chemotherapy for advanced lung cancer regardless of chronologic age.
Jimmy Ruiz,Antonius A. Miller,Janet A. Tooze,Sandrine Crane,William J. Petty,Ajeet Gajra,Heidi D. Klepin +6 more
TL;DR: Frailty predicts chemotherapy toxicity during first cycle chemotherapy and may inform toxicity risk regardless of chronologic age, multi-site pilot study finds.